Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 2/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 13/20 | 0.48 |
| ▸ | CYP11B2 | P19099 | 13/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.43 |
| ▸ | TDP2 | O95551 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13872246 | 0.88 | CYP11B1 (0.43) | MAP3K5CYP11B1CYP11B2CYP1A2CYP17A1 | |
| SCHEMBL3481109 | 0.79 | MAP3K5 (0.51) | MAP3K5CYP11B1CYP11B2CYP1A2CYP17A1 | |
| SCHEMBL13113569 | 0.79 | MAP3K5 (0.51) | MAP3K5CYP11B1CYP11B2CYP1A2CYP17A1 | |
| SCHEMBL13113767 | 0.78 | MAP3K5 (0.54) | MAP3K5CYP11B1CYP11B2CYP1A2CYP17A1 | |
| SCHEMBL13871876 | 0.76 | NOTUM (0.35) | CYP11B1CYP11B2 | |
| SCHEMBL10085794 | 0.75 | TP53 (0.61) | MAP3K5CYP11B1CYP11B2TDP2CYP3A4 | |
| SCHEMBL13871899 | 0.74 | MCHR1 (0.37) | CYP11B1CYP11B2SRD5A1 | |
| SCHEMBL21646417 | 0.73 | CYP11B2 (0.66) | CYP11B1CYP11B2CYP1A2CYP17A1CYP19A1 | |
| SCHEMBL10085486 | 0.71 | MAP3K5 (0.50) | MAP3K5CYP11B1CYP11B2CYP3A4CYP2C19 | |
| SCHEMBL13872230 | 0.70 | HTR2C (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009042907-A1 | ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2009-04-02 | — | — | WO | disclosed |